I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Ubumsulwa ≥99.0% Isithombe Esifakiwe se-Favipiravir Esimaphakathi se-COVID-19

6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Purity ≥99.0% Favipiravir Intermediate COVID-19

Incazelo emfushane:

Igama: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

I-CAS: 259793-88-9

Ubumsulwa: ≥99.0%

Iphakathi kwe-Favipiravir (CAS 259793-96-9) ekwelapheni ukutheleleka ngegciwane loMkhuhlane kanye ne-COVID-19

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Umkhiqizi onokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
I-Favipiravir yezohwebo kanye Nezixhumanisi Ezihlobene:
I-Favipiravir CAS 259793-96-9
I-2-Aminopropanediamide CAS 62009-47-6
I-Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
I-3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Chemical Properties:

Igama Lekhemikhali	I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide
Omqondofana	I-Favipiravir Intermediate;I-Favipiravir Ukungcola 4
Inombolo ye-CAS	259793-88-9
Inombolo yeCAT	I-RF-PI296
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu
I-Molecular Formula	I-C5H4BrN3O2
Isisindo samangqamuzana	218.01
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Ephuzi Ekhanyayo ukuya Ensundu
Ukuhlonza	IR, HPLC
Ukulahlekelwa Ekumisweni	≤1.0%
Izinsalela ekushiseni	≤0.20%
Ukungcola Okukodwa	≤0.50%
Ukungcola Okuphelele	≤1.0%
Izinsimbi Ezisindayo	≤20ppm
Izincibilikisi Ezisele	Hlangana nencazelo
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Favipiravir emaphakathi (CAS 259793-96-9)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

I-FAQ:

Isicelo:

I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) imaphakathi ngokuvamile ekuhlanganiseni kwe-6-Bromo-3-Hydroxypyrazine-2-Carboxamide ngokwezentengiso ebizwa ngokuthi i-Favipiravir (CAS 259793-96-9) ekwelapheni izifo ze-Influenza virus.Umzila osebenzayo nowesinyathelo-somnotho oya ku-Favipiravir.I-Favipiravir ingumkhiqizo wocwaningo ohlobene ne-COVID19, ekwelapheni iziguli ezine-COVID-19 ezinconywe yi-WHO.I-Favipiravir, eyaziwa nangokuthi i-T-705 noma i-Avigan, iyisidakamizwa esilwa namagciwane esakhiwa yi-Toyama Chemical (Fujifilm Group) yase-Japan esebenza ngokumelene namagciwane amaningi e-RNA.I-Favipiravir yagunyazwa ukumakethwa e-Japan ngo-March 2014 futhi yasetshenziselwa ukwelashwa kwe-antiviral yomkhuhlane A no-B. Ngaphezu kwegciwane lomkhuhlane, umuthi ubuye wabonisa umsebenzi omuhle wokulwa namagciwane ezinhlobonhlobo zamagciwane e-RNA, njengegciwane le-Ebola, igciwane lesihlabathi, Igciwane le-Bunia, igciwane lamarabi, njll. NgoFebhuwari 2020 i-Favipiravir yayicwaningwa e-China ukuze kuhlolwe isifo esiqhamukayo se-COVID-19 (Novel Coronavirus) futhi ibe nemiphumela emihle.